Silver nanoparticle protein corona and toxicity: A mini-review

Journal of Nanobiotechnology

Volumn 13, Issue 1, 2015, Pages

  Durán, Nelson ^a,b   Silveira, Camila P ^a   Durán, Marcela ^a   Martinez, Diego Stéfani T ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b BRAZILIAN CENTER FOR RESEARCH IN ENERGY AND MATERIALS CNPEM   (Brazil)

Author keywords

Cytotoxicity; Protein corona; Silver nanoparticles

Indexed keywords

BODY FLUIDS; CYTOTOXICITY; MAMMALS; MEDICAL NANOTECHNOLOGY; METAL NANOPARTICLES; MOLECULAR BIOLOGY; NANOPARTICLES; PROTEINS; TOXICITY;

ANTI-MICROBIAL ACTIVITY; BIOLOGICAL RESPONSE; BIOTECHNOLOGICAL APPLICATIONS; FETAL BOVINE SERUM; HUMAN SERUM ALBUMINS; NANOTECHNOLOGY INDUSTRY; PROTEIN CORONAS; SILVER NANOPARTICLES;

SILVER;

BOVINE SERUM ALBUMIN; HUMAN SERUM ALBUMIN; HYALURONIC ACID; SILVER NANOPARTICLE; TUBULIN; UBIQUITIN; ANTIINFECTIVE AGENT; NANOPARTICLE; PROTEIN CORONA; SILVER;

ADHESION; ANTIBACTERIAL ACTIVITY; CONFORMATIONAL TRANSITION; DISSOCIATION CONSTANT; DRUG CYTOTOXICITY; ENDOSOME; FETAL CALF SERUM; GENOTOXICITY; HUMAN; HYDROPHOBICITY; IMMUNOTOXICITY; LYSOSOME; MOLECULAR WEIGHT; NANOTOXICOLOGY; NEUROTOXICITY; NONHUMAN; OCCUPATIONAL HAZARD; PLASMA; PROTEIN CORONA; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN UNFOLDING; REVIEW; ANIMAL; BACTERIAL INFECTIONS; BACTERIUM; CHEMISTRY; DRUG EFFECTS; METABOLISM; MOLECULAR MODEL; NANOMEDICINE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; HUMANS; MODELS, MOLECULAR; NANOMEDICINE; NANOPARTICLES; PROTEIN CORONA; SILVER;

EID: 84940662707     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/s12951-015-0114-4     Document Type: Review

References (89)

1. Ashkarran AA, Ghavami M, Aghaverdi H, Stroeve P, Mahmoudi M (2012) Bacterial effects and protein corona evaluations: crucial ignored factors in the prediction of bio-efficacy of various forms of silver nanoparticles. Chem Res Toxicol 25:1231-1242
2. Lem KW, Choudhury A, Lakhani AA, Kuyate P, Haw JR, Lee DS, Iqbal Z, Brumlik CJ (2012) Use of nanosilver in consumer products. Rec Pat Nanotec 6:60-72
3. Faria AF, Martinez DST, Meira SMM, Moraes ACM, Brandelli A, Souza Filho AG, Alves OL (2014) Anti-adhesion and antibacterial activity of silver nanoparticles supported on graphene oxide sheets. Colloid Surf B 113:115-124
4. Rai M, Kon K, Ingle A, Durán N, Galdiero S, Galdiero M (2014) Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects. Appl Microbiol Biotechnol 98:1951-1961
5. Rai M, Ingle A, Gaikwad S, Gupta I, Yadav A, Gade A, Durán N (2015) Fungi: myconanofactory, mycoremediation and medicine. In: Deshmukh SK, Misra JK, Tiwari JP, Papp T (eds) Fungi and their applications under the series of progress in mycological research. CRC Press, USA (in press)
6. Tran QH, Nguyen VQ, Le AT (2013) Silver nanoparticles: synthesis, properties, toxicology, applications and perspectives. Adv Nat Sci Nanosci Nanotechnol 4:033001
7. Han JW, Gurunathan S, Jeong J-K, Choi Y-J, Kwon D-N, Park J-K, Kim J-H (2014) Oxidative stress mediated cytotoxicity of biologically synthesized silver nanoparticles in human lung epithelial adenocarcinoma cell line. Nanosc Res Let 9:459
8. Durán N, Marcato PD, De Conti R, Alves OL, Costa FTM, Brocchi M (2010) Potential use of silver nanoparticles on pathogenic bacteria, their toxicity and possible mechanisms of action. J Braz Chem Soc 21:949-959
9. Greulich C, Diendorf J, Simon T, Eggeler G, Epple M, Koller M (2011) Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater 7(1):347-354
10. De Lima R, Seabra AB, Durán N (2012) Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles. J Appl Toxicol 32:867-879
11. Lima R, Feitosa LO, Ballottin D, Marcato PD, Tasic L, Durán N (2013) Cytotoxicity and genotoxicity of biogenic silver nanoparticles. J Phys Conf Ser 429:012020
12. Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, Schlager JJ (2008) Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B 112:13608-13619
13. Park MV, Neigh AM, Vermeulen JP, de la Fonteyne LJ, Verharen HW, Briedé JJ, van Loveren H, de Jong WH (2011) The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomat 32:9810-9817
14. AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S (2009) Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3:279-290
15. AshaRani PV, Hande MP, Valiyaveettil S (2009) Anti-proliferative activity of silver nanoparticles. BMC Cell Biol 10:65
16. Kim Y, Suh HS, Cha HJ, Kim SH, Jeong KS, Kim DH (2009) A case of generalized argyria after ingestion of colloidal silver solution. Am J Ind Med 52:246-250
17. Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, Ryu DY (2009) Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In Vitro 23:1076-1084
18. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ (2005) In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19:975-983
19. Hussain SM, Javorina AK, Schrand AM, Duhart HM, Ali SF, Schlager JJ (2006) The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol Sci 92:456-463
20. Park S, Lee YK, Jung M, Kim KH, Chung N, Ahn EK, Lim Y, Lee KH (2007) Cellular toxicity of various inhalable metal nanoparticles on human alveolar epithelial cells. Inhal Toxicol 19:59-65
21. Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC (2005) In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 88:412-419
22. Braydich-Stolle LK, Lucas B, Schrand A, Murdock RC, Lee T, Schlager JJ, Hussain SM, Hofmann MC (2010) Silver nanoparticles disrupt GDNF/Fyn kinase signaling in spermatogonial stem cells. Toxicol Sci 116:577-589
23. Choi J, Reipa V, Hitchins VM, Goering PL, Malinauskas RA (2011) Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Toxicol Sci 123:133-143
24. Cronholm P, Karlsson HL, Hedberg J, Lowe TA, Winnberg L, Elihn K, Wallinder IO, Moller L (2013) Intracellular uptake and toxicity of Ag and CuO nanoparticles: a comparison between nanoparticles and their corresponding metal ions. Small 9:970-982
25. Grosse S, Evje L, Syversen T (2013) Silver nanoparticle-induced cytotoxicity in rat brain endothelial cell culture. Toxicol In Vitro 27:305-313
26. Ciftci H, Turk M, Tamer U, Karahan S, Menemen Y (2013) Silver nanoparticles: cytotoxic, apoptotic, and necrotic effects on MCF-7 cells. Turk J Biol 37:573-581
27. Faedmaleki F, Shirazi FH, Salarian A-A, Ashtiani HA, Rastegar H (2014) Toxicity effect of silver nanoparticles on mice liver primary cell culture and HepG2 cell line. Iran J Pharm Res 13:235-242
28. Gliga AR, Skoglund S, Wallinder IO, Fadeel B, Karlsson HL (2014) Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release. Particle Fibre Toxicol 11:11
29. Sengstock C, Diendorf J, Epple M, Schildhauer TA, Köller M (2014) Effect of silver nanoparticles on human mesenchymal stem cell differentiation. Beilstein J Nanotechnol 5:2058-2069
30. Massarsky A, Abraham R, Nguyen KC, Rippstein P, Tayabali AF, Trudeau VL, Moon TW (2014) Nanosilver cytotoxicity in rainbow trout (Oncorhynchus mykiss) erythrocytes and hepatocytes. Comp Biochem Phys C 159:10-21
31. Tiwari DK, Jin T, Behari J (2011) Dose-dependent in vivo toxicity assessment of silver nanoparticle in Wistar rats. Toxicol Mech Methods 21:13-24
32. Rahman MF, Wang J, Patterson TA, Saini UT, Robinson BL, Newport GD, Murdock RC, Schlager JJ, Hussain SM, Ali SF (2009) Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol Lett 187:15-21
33. Kawata K, Osawa M, Okabe S (2009) In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Envir Sci Tech 43:6046-6051
34. Behra R, Sigg L, Clift MJD, Herzog F, Minghetti M, Johnston B, Petri-Fink A, Rothen-Rutishauser B (2013) Bioavailability of silver nanoparticles and ions: from a chemical and biochemical perspective. J R Soc Interface 10:20130396
35. Wang B, Feng W, Zhao Y, Chai Z (2013) Metallomics insights for in vivo studies of metal based nanomaterials. Metallomics 5:793
36. Comfort KK, Maurer EI, Braydich-Stolle LK, Hussain SM (2011) Interference of silver, gold, and iron oxide nanoparticles on epidermal growth factor signal transduction in epithelial cells. ACS Nano 5:10000-10008
37. Stevanovic M, Kovacevic B, Petkovic J, Filipic M, Uskokovic D (2011) Effect of poly-alpha, gamma, l-glutamic acid as a capping agent on morphology and oxidative stress-dependent toxicity of silver nanoparticles. Int J Nanomed 6:2837-2847
38. Stevanovic M, Uskokovic V, Filipovic M, Skapin SD, Uskokovic D (2013) Composite PLGA/AgNpPGA/AscH nanospheres with combined osteoinductive, antioxidative, and antimicrobial activities. ACS Appl Mater Interfaces 5:9034-9042
39. Filipović N, Stevanović M, Radulović A, Pavlović V, Uskoković D (2013) Facile synthesis of poly(ε-caprolactone) micro and nanospheres using different types of polyelectrolytes as stabilizers under ambient and elevated temperature. Compos Part B 45:1471-1479
40. Chairuangkitti P, Lawanprasert S, Roytrakul S, Aueviriyavit S, Phummiratch D, Kulthong K, Chanvorachote P, Maniratanachote R (2013) Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways. Toxicol In Vitro 27:330-338
41. Shannahan JH, Podila R, Aldossari AA, Emerson H, Powell BA, Ke PC, Rao AM, Brown JM (2015) Formation of a protein corona on silver nanoparticles mediates cellular toxicity via scavenger receptors. Toxicol Sci 143:136-146
42. Miclăuş T, Bochenkov VE, Ogaki R, Howard KA, Sutherland DS (2014) Spatial mapping and quantification of soft and hard protein coronas at silver nanocubes. Nano Lett 14(4):2086-2093
43. Lee YK, Choi E-J, Webster TJ, Kim S-H, Khang D (2015) Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity. Inter J Nanomed 10:97-113
44. Linse S, Cabaleiro-Lago C, Xue W-F, Lynch I, Lindman S, Thulin E, Radford SE, Dawson KA (2007) Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci USA 104:8691-8696
45. Cukalevski R, Lundqvist M, Oslakovic C, Dahlback B, Linse S, Cedervall T (2011) Structural changes in apolipoproteins bound to nanoparticles. Langmuir 27:14360-14369
46. Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA (2010) What the cell "sees" in bionanoscience. J Am Chem Soc 132:5761-5768
47. Monopoli MP, Åberg C, Salvati A, Dawson KA (2012) Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 7:779-786
48. Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, Dawson KA, Linse S (2007) Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 104:2050-2055
49. Klein J (2007) Probing the interactions of proteins and nanoparticles. Proc Natl Acad Sci USA 104:2029-2030
50. Rocker C, Potzl M, Zhang F, Parak WJ, Nienhaus GU (2009) A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nat Nanotechnol 4:577-580
51. Treuel L, Malissek M, Gebauer JS, Zellner R (2010) The influence of surface composition of nanoparticles on their interactions with serum albumin. Chem Phys Chem 11:3093-3099
52. Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, Knauer SK, Bantz C, Nawroth T, Bier C, Sirirattanapan J, Mann W, Treuel L, Zellner R, Maskos M, Schild H, Stauber RH (2011) Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 5:7155-7167
53. Monopoli MP, Baldelli Bombelli F, Dawson KA (2011) Nanobiotechnology: nanoparticle coronas take shape. Nat Nanotechnol 6:11-12
54. Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli FB, Dawson KA (2011) Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 133:2525-2534
55. Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF (2009) Differential plasma protein binding to metal oxide nanoparticles. Nanotech 20:455101-455109
56. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105:14265-14270
57. Lesniak A, Fenaroli F, Monopoli MP, Abberg C, Dawson KA, Salvati A (2012) Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 6:5845-5857
58. Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S (2011) Protein-nanoparticle interactions: opportunities and challenges. Chem Rev 111:5610-5637
59. Delpino P, Pelaz B, Zhang Q, Maffre P, Nienhaus GU, Parak WJ (2014) Protein corona formation around nanoparticles-from the past to the future. Mater Horiz 1:301-313
60. Durán N, Marcato PD, Durán M, Yadav A, Gade A, Rai M (2011) Mechanistic aspects in the biogenic synthesis of extracellular metal nanoparticles by peptides, bacteria, fungi, and plants. Appl Microbiol Biotechnol 90:1609-1624
61. Durán N, Marcato PD (2012) Biotechnological routes to metallic nanoparticles production: mechanistic aspects, antimicrobial activity, toxicity and industrial applications. In: Rai M, Cioffi N (eds) Nano-antimicrobials: progress and prospects. Springer, Germany, pp 337-374 (Part 3)
62. Balachandran YL, Girija S, Selvakumar R, Tongpim S, Gutleb AC, Suriyanarayanan S (2013) Differently environment stable bio-silver nanoparticles: study on their optical enhancing and antibacterial properties. PLoS One 8:e77043
63. Eckhardt S, Brunetto PS, Gagnon J, Priebe M, Giese B, Fromm KM (2013) Nanobio silver: it's interactions with peptides and bacteria, and it's uses in medicine. Chem Rev 113:4708-4754
64. Edmundson MC, Capeness M, Horsfall L (2014) Exploring the potential of metallic nanoparticles within synthetic biology. New Biotechn 31:572-578
65. SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks) (2014) Nanosilver: safety, health and environmental effects and role in antimicrobial resistance. http://ec.europa.eu/dgs/health_consumer/dyna/enews/enews.cfm?al_id=1494 . Accessed June 2014
66. Treuel L, Malissek M, Grass S, Diendorf J, Mahl D, Meyer-Zaika W, Epple M (2012) Quantifying the influence of polymer coatings on the serum albumin corona formation around silver and gold nanoparticles. J Nanopart Res 14:1-12
67. Ravindran A, Singh A, Raichur AM, Chandrasekaran N, Mukherjee A (2010) Studies on interaction of colloidal Ag nanoparticles with bovine serum albumin (BSA). Colloids Surf B Biointerfaces 76:32-37
68. Mariam J, Dongre P, Kothari D (2011) Study of interaction of silver nanoparticles with bovine serum albumin using fluorescence spectroscopy. J Fluoresc 21:2193-2199
69. Podila R, Chen R, Ke PC, Brown JM, Rao AM (2012) Effects of surface functional groups on the formation of nanoparticle-protein corona. Appl Phys Lett 101:263701
70. Shannahan JH, Lai X, Ke PC, Podila R, Brown JM, Witzmann FA (2013) Silver nanoparticle protein corona composition in cell culture media. PLoS One 8:e74001
71. Kittler S, Greulich C, Gebauer JS, Diendorf J, Treuel L, Ruiz LJM, Gonzalez-Calbet JM, Vallet-Regi M, Zellner R, Koller M, Epple M (2010) The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles. J Mater Chem 20:512-518
72. Kittler S, Greulich C, Diendorf J, Köller M, Epple M (2010) Toxicity of silver nanoparticles increases during storage due to slow dissolution under release of silver ions. Chem Mater 22:4548-4554
73. Liu R, Sun F, Zhang L, Zong W, Zhao X, Wang L, Wu R, Hao X (2009) Evaluation on the toxicity of nanoAg to bovine serum albumin. Sci Total Environ 407:4184-4188
74. Casals E, Pfaler T, Duschl A, Oostingh GJ, Puntes VF (2011) Hardening of the nanoparticle-protein corona in metal (Au, Ag) and oxide (Fe3O4, CoO, and CeO2) nanoparticles. Small 7:3479-3486
75. Laloy J, Minet V, Alpan L, Mullier F, Beken S, Toussaint O, Lucas S, Dogné J-M (2014) Impact of silver nanoparticles on haemolysis, platelet function and coagulation. Nanobiomedicine 1:1-9
76. Saptarshi SR, Duschl A, Lopata AL (2013) Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotech 11:1-12
77. Pearson RM, Juettner VV, Hong S (2014) Biomolecular corona on nanoparticles: a survey of recent literature and it implications in targeted drug delivery. Front Chem 2:1-7
78. Beneti F, Fedel M, Minati L, Speranza G, Migliaresi C (2013) Gold nanoparticles: role of size and surface chemistry on blood protein adsorption. J Nanopart Res 15(1694):1-9
79. Sakulkhu U, Mahmoudi M, Maurizi L, Salaklang J, Hofmann H (2014) Protein corona composition of superparamagnetic iron oxide nanoparticles with various physico-chemical properties and coatings. Sci Reports 4:1-9
80. Feng S, Lin D, Lin J, Li B, Huang Z, Chen G, Zhang W, Wang L, Pan J, Chen R, Zeng H (2013) Blood plasma surface-enhanced Raman spectroscopy for non-invasive optical detection of cervical cancer. Analyst 138:3967-3974
81. Gebauer JS, Malissek M, Simon S, Knauer SK, Maskos M, Stauber RH, Peukert W, Treuel L (2012) Impact of the nanoparticle-protein corona on colloidal stability and protein structure. Langmuir 28:9673-9679
82. Chen R, Choudhary P, Schurr RN, Bhattacharya P, Brown JM, Ke PC (2012) Interaction of lipid vesicle with silver nanoparticle-serum albumin protein corona. Appl Phys Lett 100:013703
83. Monteiro-Riviere NA, Samberg ME, Oldenburg SJ, Riviere JE (2013) Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations? Toxicol Lett 220:286-293
84. Wen Y, Geitner NK, Chen R, Ding F, Chen P, Andorfer RE, Govindan PN, Ke PC (2013) Binding of cytoskeletal proteins with silver nanoparticles. RSC Adv 3:22002-22007
85. Ding F, Radic S, Choudhary P, Chen R, Brown JM, Pu Chun Ke PC (2013) Direct observation of silver nanoparticle-ubiquitin corona formation. Nanosc. 5:9162-9169
86. Walkey CD, Olsen JB, Song F, Liu R, Guo H, Olsen DWH, Cohen Y, Emili A, Chan WCW (2014) Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano 8:2439-2455
87. Eigenheer R, Castellanos ER, Nakamoto MY, Gerner KT, Lampeb AM, Wheeler KE (2014) Silver nanoparticle protein corona composition compared across engineered particle properties and environmentally relevant reaction conditions. Environ Sci Nano 1:238-247
88. Gnanadhas DP, Thomas MB, Thomas R, Raichur AM, Chakravortty D (2013) Interaction of silver nanoparticles with serum proteins affects their antimicrobial activity in vivo. Antimicrob Agents Chemother 57:4945-4955
89. Kennedy DC, Orts-Gil G, Lai C-H, Moller L, Haase A, Luch A, Seeberger PH (2014) Carbohydrate functionalization of silver nanoparticles modulates cytotoxicity and cellular uptake. J Nanobiotechnol 12:59